(R)-(2,3-dimethoxyphenyl)(1-(2-(4-fluorophenyl)ethyl)piperidin-4-yl)methanol,
4-piperidinemethanol, alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (alpha-R)-,
alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenylethyl))-4-piperidine methanol,
M100907,
MDL 100,907,
MDL 100105,
MDL 100907,
MDL-100,907,
MDL-100907,
MDL100105,
volinanserin,
Mdl 100907,
SCHEMBL4227186,
HXTGXYRHXAGCFP-NRFANRHFSA-N,
ZINC1851117,
MDL 100009,
B7605,
MDL 100907, (S)-(-)-,
(alphaS)-alpha-[1-(4-Fluorophenethyl)-4-piperidinyl]-2,3-dimethoxybenzyl alcohol,
(S)-(2,3-Dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol,
(S)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol,
175673-57-1,
Volinanserin,
CID11953651,
(-)-MDL 100907,
(R)-(2,3-Dimethoxyphenyl)(1-(4-fluorophenethyl)piperidin-4-yl)methanol,
139290-65-6,